IMMP - Immutep completes A$60M private placement to expand clinical programs

Immutep (IMMP) has received commitments for a A$60M two-tranche private placement of new ordinary shares.The Placement will involve the issue of New Shares at an issue price of A$0.52/share. The proceeds will be used to fund the expansion of clinical programs and to commence the process characterization, process validation for efti commercial manufacturing (2,000 litre scale) and working capital purposes. Settlement of the first tranche is expected to occur on June 25, with the issuance of New Shares expected on June 28, 2021. Assuming shareholder approval is obtained for the second tranche, settlement is expected on July 29, with the issuance of New Shares on July 30, 2021. Following completion of the issue of the first tranche of the Placement, Immutep will conduct an offer of New Shares under a non-underwritten share purchase plan ((SPP)). The SPP will provide each Eligible Shareholder with the opportunity to apply for up to

For further details see:

Immutep completes A$60M private placement to expand clinical programs